Frazier Healthcare Partners to acquire MatrixCare from Resmed
What's the deal? Frazier Healthcare PartnersDealroom has a profile for this one. Try Dealroom → has signed a definitive agreement to acquire MatrixCareDealroom has a profile for this one. Try Dealroom →, a cloud-based electronic health record (EHR) software provider, from medical-device maker ResmedDealroom has a profile for this one. Try Dealroom →. The transaction is expected to close in the third quarter of 2026, subject to customary closing conditions. Terms were not disclosed.
What each side does: MatrixCare builds software for out-of-hospital care settings — skilled nursing, senior living, home health, hospice, and life plan communities — serving more than 15,000 providers. Frazier, founded in 1991, is a private equity firm focused exclusively on healthcare that has raised over $11 billion and invested in more than 200 companies.
Why now? For Resmed, the sale sharpens its focus. "This divestiture is aligned with Resmed's 2030 strategy with a focused approach to portfolio management," said Mick Farrell, chairman and chief executive officer of Resmed.
What's the endgame? Frazier says it spent several years evaluating post-acute care technology before landing on MatrixCare. It plans to "invest aggressively in product innovation," said Clarissa BermanDealroom has a profile for this one. Try Dealroom →, a principal at the firm.
The deal covers MatrixCare and related products including Healthcare First, Citus, and home health and hospice solutions.
The signal: The acquisition puts a Best in KLAS-winning platform under specialist ownership as the post-acute care landscape shifts toward home- and facility-based settings. It also marks another carve-out where a device maker sheds software to concentrate on its core business.
Read more: AP News
